ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020 E Lilley, SC Stanford, DE Kendall, SPH Alexander, G Cirino, JR Docherty, ... British journal of pharmacology 177 (16), 3611, 2020 | 822 | 2020 |
Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo NA Jones, AJ Hill, I Smith, SA Bevan, CM Williams, BJ Whalley, ... Journal of Pharmacology and Experimental Therapeutics 332 (2), 569-577, 2010 | 449 | 2010 |
Phytocannabinoids as novel therapeutic agents in CNS disorders AJ Hill, CM Williams, BJ Whalley, GJ Stephens Pharmacology & therapeutics 133 (1), 79-97, 2012 | 435 | 2012 |
Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro … FA Iannotti, CL Hill, A Leo, A Alhusaini, C Soubrane, E Mazzarella, ... ACS chemical neuroscience 5 (11), 1131-1141, 2014 | 431 | 2014 |
Planning experiments: Updated guidance on experimental design and analysis and their reporting III MJ Curtis, SPH Alexander, G Cirino, CH George, DA Kendall, PA Insel, ... British Journal of Pharmacology 179 (15), 3907-3913, 2022 | 396 | 2022 |
Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures NA Jones, SE Glyn, S Akiyama, TDM Hill, AJ Hill, SE Weston, ... Seizure 21 (5), 344-352, 2012 | 327 | 2012 |
Differential expression of voltage-activated Na+ currents in two prostatic tumour cell lines: contribution to invasiveness in vitro JA Grimes, SP Fraser, GJ Stephens, JEG Downing, ME Laniado, ... FEBS letters 369 (2-3), 290-294, 1995 | 295 | 1995 |
Cannabidivarin is anticonvulsant in mouse and rat AJ Hill, MS Mercier, TDM Hill, SE Glyn, NA Jones, Y Yamasaki, ... British journal of pharmacology 167 (8), 1629-1642, 2012 | 209 | 2012 |
A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology: Reproducibility of natural product research AA Izzo, M Teixeira, SPH Alexander, G Cirino, JR Docherty, CH George, ... British Journal of Pharmacology 177 (10), 2169-2178, 2020 | 201 | 2020 |
Identification of residues in the N terminus of α1B critical for inhibition of the voltage-dependent calcium channel by Gβγ C Cantı, KM Page, GJ Stephens, AC Dolphin Journal of Neuroscience 19 (16), 6855-6864, 1999 | 163 | 1999 |
Δ9‐Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats AJ Hill, SE Weston, NA Jones, I Smith, SA Bevan, EM Williamson, ... Epilepsia 51 (8), 1522-1532, 2010 | 158 | 2010 |
Hyperpolarization-activated currents in presynaptic terminals of mouse cerebellar basket cells AP Southan, NP Morris, GJ Stephens, B Robertson The Journal of Physiology 526 (Pt 1), 91, 2000 | 147 | 2000 |
Identification of the amino terminus of neuronal Ca2+ channel α1 subunits α1B and α1E as an essential determinant of G-protein modulation KM Page, C Cantı́, GJ Stephens, NS Berrow, AC Dolphin Journal of Neuroscience 18 (13), 4815-4824, 1998 | 145 | 1998 |
The synaptic vesicle glycoprotein 2A ligand levetiracetam inhibits presynaptic Ca2+ channels through an intracellular pathway C Vogl, S Mochida, C Wolff, BJ Whalley, GJ Stephens Molecular pharmacology 82 (2), 199-208, 2012 | 143 | 2012 |
CB1 receptor allosteric modulators display both agonist and signaling pathway specificity GL Baillie, JG Horswill, S Anavi-Goffer, PH Reggio, D Bolognini, ... Molecular pharmacology 83 (2), 322-338, 2013 | 133 | 2013 |
Calcium channel β subunit promotes voltage-dependent modulation of α1B by Gβγ A Meir, DC Bell, GJ Stephens, KM Page, AC Dolphin Biophysical journal 79 (2), 731-746, 2000 | 121 | 2000 |
The Cav2.3 calcium channel antagonist SNX‐482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain EA Matthews, LA Bee, GJ Stephens, AH Dickenson European journal of neuroscience 25 (12), 3561-3569, 2007 | 117 | 2007 |
The intracellular loop between domains I and II of the B-type calcium channel confers aspects of G-protein sensitivity to the E-type calcium channel KM Page, GJ Stephens, NS Berrow, AC Dolphin Journal of Neuroscience 17 (4), 1330-1338, 1997 | 115 | 1997 |
Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) B Whalley, C Williams, G Stephens, T Hill US Patent 10,729,665, 2020 | 108 | 2020 |
Voltage-gated sodium (NaV) channel blockade by plant cannabinoids does not confer anticonvulsant effects per se AJ Hill, NA Jones, I Smith, CL Hill, CM Williams, GJ Stephens, BJ Whalley Neuroscience Letters 566, 269-274, 2014 | 102 | 2014 |